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Abstract
In colon cancer, mutation of the Wnt repressor Adenomatous polyposis coli (APC) leads to a state 
of aberrant and unrestricted “high-activity” signaling. However, relevance of high Wnt tone in 
non-genetic human disease is unknown. Here we demonstrate that distinct Wnt activity functional 
states determine oligodendrocyte precursor (OPC) differentiation and myelination. Murine OPCs 
with genetic Wnt dysregulation (high tone) express multiple genes in common with colon cancer 
including Lef1, SP5, Ets2, Rnf43 and Dusp4. Surprisingly, we find that OPCs in lesions of 
hypoxic human neonatal white matter injury upregulate markers of high Wnt activity and lack 
expression of APC. Finally, we show lack of Wnt repressor tone promotes permanent white matter 
injury after mild hypoxic insult. These findings suggest a state of pathological high-activity Wnt 
signaling in human disease tissues that lack pre-disposing genetic mutation.
Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, 
subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms
^Authors for correspondence: Stephen P.J. Fancy, DVM, PhD, Mission Bay Campus, 675 Nelson Rising Lane, Sandler Neuroscience 
Center, Rm. 260, San Francisco, CA 94158, FancyS@stemcell.ucsf.edu. David H. Rowitch, MD, PhD, 533 Parnassus Avenue, U503, 
San Francisco, CA 94143, tele: (415) 476-7242; fax: (415) 476-9976, rowitchd@peds.ucsf.edu.
*These authors contributed equally
Author Contributions
S.P.J.F. conceived of and performed all experiments and analysis, with the exception of the following: E.P.H performed and analyzed 
all experiments related to in vitro OLP cultures. J.C.S., T.J.Y. and L.S. helped analyze Wnt pathway activation in murine hypoxic 
injury. S.E.B. performed bioinformatics. E.J.H. procured human brain developmental tissue. S.L. provided advice on ChIP protocol 
and analysis. D.H.R conceived the experiments and oversaw all aspects of the analysis. The paper was written by S.P.J.F. and D.H.R.
HHS Public Access
Author manuscript
Nat Neurosci. Author manuscript; available in PMC 2014 October 01.
Published in final edited form as:
Nat Neurosci. 2014 April ; 17(4): 506–512. doi:10.1038/nn.3676.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Introduction
Activation of canonical Wnt signaling results in the stabilization of β-catenin and its 
translocation to the nucleus to associate with TCF family transcriptional protein partners. In 
the intestine, low activity signaling mediated by TCF4-β-catenin is necessary for normal 
turnover of the epithelium throughout life and maintenance of Lgr5+ crypt stem cells (1). A 
fine balance exists in the colon between Wnt pathway activation and inhibition in the 
determination of this low activity state, and numerous control mechanisms therefore exist to 
limit Wnt signaling levels (2). Germ line mutation of adenomatous polyposis coli (APC) 
causes familial predisposition to colon cancer (3). In the absence of APC, failure to degrade 
β-catenin results in unrestricted Wnt signaling, which reaches a threshold to elicit expression 
of LEF1(4). This high LEF1- β-catenin activity state drives uncontrolled epithelial growth 
and colon adenocarcinoma (5, 6). Similar low/high Wnt signaling states also distinguish 
normal hematopoiesis versus leukemias with mutations in Wnt pathway repressor genes (7). 
Many other markers have been identified from expression profiling that distinguish colon 
cancer from normal intestinal stem cell populations (3). Some of these factors have been 
shown to function as suppressors of the Wnt pathway, such as Rnf43, an E3 ligase that 
ubiquitinates frizzled receptors (8). Although in principle, such markers might be useful in 
detecting a high-activity state in a variety of human diseases, it has yet to be shown whether 
pathological Wnt signaling can be achieved in non-genetically-based conditions.
Oligodendrocytes are the myelinating cells of the central nervous system (CNS) and are 
cellular targets of injury in human disease such as multiple sclerosis (MS) (9) and neonatal 
white matter injury (WMI) leading to cerebral palsy (CP) (10, 11). Pathological analysis of 
these demyelinated lesions has revealed the presence of oligodendrocyte precursor cells 
(OPCs) arrested at an immature/premyelinating stage (12–14). As remyelination of 
experimental rodent demyelinated lesions is reproducibly efficient, why do human lesions 
fail to myelinate? This question prompted us to investigate whether a high pathological Wnt 
tone could be demonstrated in human neonatal subcortical white matter affected by hypoxic 
ischemic encephalopathy (HIE), despite the fact that this is an injury-induced, non-genetic 
condition.
Results
Common markers of high Wnt tone across diverse tissue types
Although Wnt signaling can delay timing of OPC differentiation (15–18), it is unclear 
whether signaling can achieve pathological-high levels to account for fixed demyelinated 
lesions in human injury. Indeed, the notion of a high-activity Wnt signaling state in human 
WMI, or other non-genetic disorders, has not been investigated. To define markers for high 
Wnt signaling across various tissues, we first compared mRNA transcripts upregulated in 
mouse Wnt-activated OPCs (Olig2cre/DA-Cat: (15)) and human colon carcinomas that are 
commonly driven by mutations of the Wnt pathway such as loss of APC function (Suppl. 
Tab. 1; (2, 3)). This revealed over 47 genes with significant upregulation (Suppl. Tab. 1). 
We reasoned that such information might identify both novel targets of the Wnt pathway in 
colon cancer and new high-activity pathway markers in OPCs (Fig. 1a). We focused on 
LEF1, SP5, RNF43, DUSP4 and ETS2 based on the following criteria: (1) upregulation 
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associated with high-activity Wnt signaling in other studies, (2) known functions in colon 
cancer and (3) markers available for immunohistochemistry (IHC) in human and rodent 
samples. All five markers were expressed in adenocarcinoma (Fig. 1b). DUSP4, a MAP-
kinase phosphatase protein has not previously been reported as a Wnt-activated target; thus, 
our approach serves as a gene discovery tool.
High activity Wnt elicits Lef1 and OPC maturation arrest
In the adult mammalian CNS, APC expression is specific to OPCs upon cell cycle exit and 
mature oligodendrocytes (Suppl. Fig. 1). We generated Olig2cre, APCfl/fl mice, which 
resulted in ~85% efficiency of APC protein loss in OPCs and ~15% “escapees” that failed to 
delete APC (Suppl. Fig. 2). While numbers of OPCs were normal in brain and spinal cord 
(Suppl. Fig. 2b), APC-deficient OPCs showed irreversible maturation arrest and failed to 
express myelin regulatory factor (Fig. 2a)(19), or the mature oligodendrocyte markers Cnp, 
Mag (Fig. 2a), Mal, Plp and Fa2h (Suppl. Fig. 2b, Suppl. Fig. 3b). APC-deficient OPCs 
expressed greatly elevated levels of the Wnt transcriptional target Axin2 (Fig. 2b, Suppl. Fig. 
4). Only “escapees” of Olig2-cre activity that expressed APC were capable of differentiation 
to NOGO-A-positive mature oligodendrocytes (Suppl. Fig. 3a).
High-activity Wnt signaling in colon cancer reaches a threshold to elicit the expression of 
LEF1, a reported target of the Wnt pathway, and involves a subsequent switch from a TCF4-
β–catenin to a LEF1-β–catenin complex (Fig. 3a; (4)). Once activated, LEF1 participates in a 
feed-forward loop driving its own expression, which is critical for the high-activity state. As 
shown (Fig. 3b), Lef1 is not expressed during normal oligodendrocyte development; 
however, we observed robust Lef1 expression in the corpus callosum and spinal cord of 
Olig2-cre, APCfl/fl animals, suggesting a high Wnt signaling threshold had been reached. 
Such APC-deficient OPCs expressed high levels of Axin2 and remained permanently 
undifferentiated (Fig. 2b, Suppl. Fig. 5), in keeping with other recent findings (20). 
Conversely, Axin2 expression was undetectable in APC-intact, Tcf4-positive OPCs (Fig. 
3b). A fascinating finding is that such OPCs express the high activity markers SP5, Dusp4 
and Ets2 (Fig. 4a and 4b). However, unlike Wnt-driven cancers of gut and hematopoetic 
systems, which respond to mitogenic Wnt signaling, we did not observe hyperproliferation 
of OPCs or glioma (Suppl. Fig. 6). In summary, high Wnt tone in OPCs is marked by the 
expression of Lef1 and acts purely to block differentiation (Fig. 3a).
SP5 is a Wnt target that inhibits myelin gene expression
We investigated SP5, encoding a zinc finger type transcription factor of the SP/KLF family, 
which was the most highly upregulated transcription factor in Wnt-activated OPCs. We first 
asked whether SP5 was a direct Wnt target. As shown (Fig. 5a), Tcf4 binds to consensus 
binding sites at the SP5 locus in OPCs as shown by chromatin immunoprecipitation (ChIP). 
SP5 luciferase reporter gene activation was observed in the presence of β-catenin and 
endogenous Tcf4 in OPCs, and was inhibited by dominant-negative Tcf4 (Fig. 5b). The 
related factor SP1 binds to the myelin basic protein (MBP) enhancer to activate expression 
(21). As shown (Fig. 5d, Suppl. Fig. 7), SP5 directly bound multiple myelin gene loci in 
OPCs, but not mature oligodendrocytes while the converse was the case for SP1, which 
showed preferential binding at myelin genes in mature oligodendrocytes. SP5 expression 
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inhibited baseline MBP levels, while SP1-induced activation of MBP enhancer activity (Fig. 
5c). These findings indicate direct activation of SP5 by Wnt signaling within OPCs, and that 
SP5 proteins inhibit myelin gene expression through competition with SP1.
SP5-null animals are viable without known gut or white matter abnormalities (22). 
Consistent with this, we found that oligodendrocyte development proceeds normally in 
SP5−/− animals (Fig. 5e, Suppl. Fig. 8). We next used focal injection of lysolecithin into 
adult spinal cord white matter to assess kinetics of remyelination. Compared to low SP5 
expression levels in developing WT OPCs (Fig. 4a), we observed increased SP5 expression 
levels in OPCs during remyelination (Fig. 5f). Strikingly, SP5−/− animals showed 
acceleration of OPC differentiation during remyelination and precocious expression of 
myelin genes Mag, Cnp, Fa2h, Mbp and Plp at 7-days post-lesion (dpl)(Fig. 5f and 5g, 
Suppl. Fig. 9). These findings indicate that SP5 is a direct Wnt target and the first 
transcription factor identified whose function is required to delay kinetics of normal 
remyelination. Further, they suggest remyelination achieves an “intermediate” Wnt signaling 
state characterized by increased expression of SP5 and requirement for SP5-function.
OPCs in human WMI express multiple novel genes in common with colon cancer
Subcortical WMI occurs in term infants that suffer severe hypoxic-ischemic encephalopathy 
(HIE; Fig. 6a). As shown (Fig. 6b–d, and g), immature oligodendrocyte lineage cells in such 
lesions expressed markers of high activity Wnt signaling (i.e., LEF1, SP5, ETS2, DUSP4, 
RNF43). Surprisingly, such OPCs (Olig2+, Nkx2.2+) that co-expressed LEF1 and SP5 (Fig. 
6c and d) in these lesions were uniformly APC-negative (n =300 Lef1+ cells, three 
independent HIE cases)(Fig. 6e), suggesting deficient Wnt repressor tone. Indeed, RNF43 
was expressed in cells with the simple bipolar morphology of OPCs in neonatal WMI (Fig. 
6f), and in a chronic white matter lesion from a 12-year old child with CP (Fig. 6h), 
consistent with the possibility of a long-standing high-activity Wnt signaling state.
Loss of Wnt repressor tone determines transition to high activity signaling
Given these findings, we further investigated the function of Wnt repressor tone during 
remyelination, and compared Lef1 expression in animals that were either wild type, Axin2−/
− or Olig2-cre, APCfl/fl (Fig. 7a). Whilst Axin2 is a direct target of the Wnt pathway (Fig. 
2b), Axin2−/− mice also have a hyperactive Wnt tone, as the Axin2 protein is a known 
repressor of the pathway through functions in the β–catenin degradation complex (16, 23). 
In the lysolecithin gliotoxic model, white matter oligodendrocytes are initially killed off and 
must be replaced by newly generated OPCs. As expected, based on findings from 
development (Fig. 2), APC-null oligodendrocytes show a permanent block in remyelination 
with persistence of Lef1 and Axin2 expression for as long as 90 dpl (Fig. 7c, Suppl. Fig. 10). 
Moreover, we observed that numbers of Lef1+ cells were increased in lesions inversely to 
Wnt repressor tone (Fig. 7b), suggesting that the percentage of Lef1+/Olig2+ OPCs 
comprises an index of Wnt activity levels.
To assess whether Wnt repressor function regulates neonatal WMI, we tested effects of 
mild/chronic neonatal hypoxemia (10% FiO2, P3–P7) on white matter volume throughout 
the brain. In wild type mice, this treatment causes only transient delay of myelination at P11 
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(data not shown) with full recovery of white matter volume by P40 (Fig. 7d and e). In 
contrast, Axin2−/− mice demonstrated selective white matter volume deficits, while grey 
matter volume was not significantly affected. Together these findings suggest that a 
deficient Wnt repressor tone and hypoxia is sufficient for permanent effects on white matter.
Discussion
Pathological Wnt signaling in cancers of colon and blood are associated with a high-activity 
state in genetically predisposed cells. We demonstrate for the first time that various Wnt 
pathway activity states can exist in oligodendrocyte lineage, and distinguish the normal 
process of myelination from pathological OPC differentiation block, in a dose-dependent 
fashion. We show that developing OPCs require APC function to prevent transition to a 
high-activity Wnt signaling state that permanently blocks their differentiation. Considering 
the requirement for APC in both colonic stem cells and OPCs, it is possible that individuals 
with familial adenomatous polyposis (FAP) syndrome, who carry heterozygous loss-of-
function APC mutations, who are reported to suffer from intellectual disability (24), might 
be prone to WMI. OPCs with high-activity Wnt signaling express many known markers in 
common with colon cancer including Lef1, SP5, Ets2, Rnf43 (4, 8, 25, 26) as well as newly 
identified Dusp4 (this study). Further studies are needed to define the tissue-specific 
functions of such putative pathway components downstream of Wnt signaling in OPCs. As 
one example, we found that SP5 is a direct Tcf4 target, which acts in a competitive balance 
with the related transcription factor SP1 for binding at mature myelin gene loci, and is 
essential to inhibit kinetics of OPC differentiation after demyelinating injury.
Akin to the colon, high activity Wnt signaling in OPCs reaches the threshold to induce the 
expression of Lef1, with a subsequent switch from a TCF4-β–catenin to a LEF1-β–catenin 
dependent complex. We show that remyelination in a simple murine model and wild type 
genetic background does not result in high activity Wnt signaling, as Lef1-expressing OPCs 
are not observed. Nor did we observe Lef1 expression when other factors such as hypoxia or 
LPS-induced inflammation were added to gliotoxic injury (Fig. 7a and data not shown). In 
contrast, OPCs that carry heterozygous or homozygous mutations of Axin2 or APC repressor 
genes show Lef1 expression in OPCs in a dose dependent manner. Thus, Wnt repressor tone 
is the critical factor that regulates transition to a high activity state after injury. Indeed, 
Axin2−/− mice subjected to mild hypoxia develop fixed deficits in white matter volume at 
P40 in dramatic contrast to wild type controls that show no injury whatsoever.
Genetic alterations in Wnt pathway repressors lead to certain cancers as well as non-
cancerous pathology (e.g., bone hypertrophy) (27). Surprisingly, we found that OPCs in 
human neonatal HIE (i.e., a non-genetic lesion) expressed high-activity markers similar to 
colon cancer, suggesting a parallel state of pathological Wnt signaling. This pathological 
Wnt tone in OPCs in human HIE goes some way to explaining why human lesions may fail 
to myelinate. However, further investigation is needed to determine how this high-activity 
state is achieved. One possibility is that hypoxic and/or inflammatory factors result in 
epigenetic dysregulation of Wnt repressor tone. In this regard, it is noteworthy that OPCs 
with high-Wnt tone consistently lacked APC expression. APC might be regulated at the 
transcriptional, translational level (28), or could be mis-localized within OPCs (29) in the 
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setting of injury. For example, hypoxia in colon cancer cell lines affects APC levels via a 
direct effect of hypoxia inducible factors (HIFs) at the APC promoter (30). Secondly, 
several previous studies indicate that epigenetic silencing of Wnt repressors in certain colon 
cancers may contribute to disease progression (31, 32), which could represent a pre-
cancerous ‘kindling state’ that selects for somatic mutations. Further research is needed to 
establish epigenetic mechanisms that mitigate against Wnt repressor tone in human WMI 
and the extent to which a high-activity Wnt signaling state exists in other non-genetically-
based human diseases.
Methods
Human HIE neonatal tissue and human colon cancer tissue
All human HIE tissue was collected in accordance with guidelines established by the 
University of California San Francisco Committee on Human Research (H11170-19113-07) 
as previously described (16, Fancy et al., Nat Neurosci 14, 1009 (2011)). Immediately after 
procurement, all brains were immersed in phosphate buffered saline with 4% 
paraformaldehyde for three days. On day 3, the brain was cut in the coronal plane at the 
level of the Mamillary Body and immersed in fresh 4% paraformaldehyde/PBS for an 
additional three days. Post fixation, all tissue samples were equilibrated in PBS with 30% 
sucrose for at least 2 days. Following sucrose equilibration, tissue was placed into molds and 
embedded with OCT for 30 minutes at room temperature followed by freezing in dry ice-
chilled ethanol. UCSF neuropathology staff performed brain dissection and its evaluation. 
The diagnosis of hypoxic ischemic encephalopathy (HIE) requires clinical and pathological 
correlation; no widely accepted diagnostic criteria is present for the pathological diagnosis 
of HIE. None of the HIE cases evaluated in this study were identical but did show consistent 
evidence of diffuse white matter gliosis, as evaluated by the qualitative increase in the 
number of GFAP positive cells in addition to the increased intensity of GFAP staining.
Human colon cancer samples were from US Biomax, T055 colon cancer tissue array (4×
(2×3) array) with 6 cases/24 cores per slide.
Comparison of transcripts in Wnt-activated OPCs with human colon carcinomas
We retrieved log(2) fold-change expression values from a previous study using Olig2-
Cre/DA-Cat mice (15, Fancy et al., Genes Dev 23, 1571 (2009)) and another on colon cancer 
RNA profiling (3, Nature 487, 330 (2012)). Transcripts elevated in either data set or with a 
positive normalized “domain knowledge score” (DKS) were selected (Suppl Table 1). 
Normalized DKS was defined as the ratio of the number of articles in PubMed supporting 
upregulation vs. downregulation of each transcript. The PubMed query terms for 
upregulation were: (“elevated expression” OR “upregulated” OR “increase” OR 
“overexpression” OR “highly expressed” OR “enhanced expression”) AND (“colorectal” 
OR “colon” OR “rectal”). The PubMed query terms for downregulation were: (“reduced 
expression” OR “downregulated” OR “decrease”) AND (“colorectal” OR “colon” OR 
“rectal”).
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Mice
Animal husbandry and procedures were performed according to UCSF guidelines under 
IACUC approved protocols.
APC-fl/fl—A conditional (floxed) allele of APC provided by Dr. R. Fodde (Leiden 
University) (Robanus-Maandag, E.C., et al., Carcinogenesis, 31(5): p. 946–52 (2010)). 
Through intercrosses with an early Olig2 pan lineage cre-recombinase we can achieve 
conditional knockout of APC in OPCs.
SP5-LacZ—The SP5-LacZ mouse has been described previously (22, Harrison et al., 
Developmental biology 227, 358 (2000)) and has a LacZ knocked into the SP5 locus.
Axin2-LacZ—The Axin2-LacZ mouse has been described previously (Lustig, B, et al. Mol 
Cell Biol 22:1184–1193 (2002)). The LacZ insert mimics the expression pattern of Axin2 
but does not lead to a detectable phenotype in the heterozygous state. In the homozygous 
state, this effectively acts as an Axin2 null animal.
Olig2-tva-cre—A multi-functional mouse line was constructed previously (Schüller, U, et 
al. Cancer Cell 14:123–134 (2008)) by inserting tva, an avian-specific retroviral receptor, 
and an IRES-cre recombinase cassette into the endogenous Olig2 locus by homologous 
recombination. This Olig2-cre allowed for cre mediated activity in oligodendrocyte lineage 
cells.
Immunohistochemistry and antibodies
The primary antibodies used were as follows: APC (1:100 mouse monoclonal OP80, 
Calbiochem), Lef1 (1:200 Rabbit mAb C12A5, Cell Signaling), anti-human Lef1 (1:100 
rabbit polyclonal Ab22884, Abcam), RNF43 (1:200 rabbit polyclonal Ab84125, Abcam), 
ETS2 (1:200 chicken polyclonal Ab17901, Abcam), DUSP4 (1:200 rabbit polyclonal 
Ab60229, Abcam), SP5 (1:200 rabbit polyclonal Ab36593, Abcam), Tcf4 (1:100 mouse 
monoclonal 6H5-3, Upstate), Olig2 (1:3000 rabbit polyclonal from CD Stiles, Harvard), 
Nkx2.2 (1:100 mouse monoclonal, Developmental Studies Hybridoma Bank), PDGFRα 
(1:200 rat 558774, BD Biosciences), NOGO-A (1:200 rabbit, Millipore), and GFAP (1:500 
mouse, Sigma).
Murine lysolecithin focal demyelination model
Demyelinated lesions were produced in the ventrolateral or dorsal spinal cord white matter 
of 8–10 week old Axin2 null, Olig2cre:APCfl/fl and wild-type littermate mice. Anaesthesia 
was induced and maintained with inhalational isoflurane/oxygen, supplemented with 0.05 
ml of buprenorphine (Vetergesic 0.05 mg/ml) given subcutaneously. Having exposed the 
spinal vertebrae at the level of T12/T13, tissue was cleared overlying the intervertebral 
space, and the dura was pierced with a dental needle just lateral to midline. A Hamilton 
needle was advanced through the pierced dura at an angle of 45° and 0.5μl 1% lysolecithin 
(Lα-lysophosphatidylcholine) was injected into the ventrolateral white matter.
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Murine developmental Chronic Hypoxia and statistics
Chronic hypoxic rearing was performed as previously described (Weiss et al., Experimental 
Neurology, 189: pp. 141–149 (2004)). Briefly, C57/B6 litters were culled to a size of 8 pups, 
cofostered with a CD1 dam and reared from P3 to P11 in a ventilated hypoxia chamber set 
to 10% 02 (A-Chamber, Biospeherix, Ltd. Lacona, NY). Following hypoxic rearing animals 
were returned to normal housing, weened at P28, and sacrificed at P40 as were normoxic 
controls. Statistical significance for the interaction effect of chronic hypoxic rearing and 
Axin2 deletion was determined by Two-Way ANOVA tests using the StatPlus software 
plugin (AnalystSoft) for Microsoft Excel. P-values of less than 0.05 are reported as 
significant.
Cell counts and statistical measures
For all cell counts, at least four animals per genotype were used for each time point 
indicated. Cells were counted on three or more non-adjacent sections per mouse and 
presented as an average +/− standard deviation. Statistical comparisons of cell counts were 
established using Student t test. No statistical methods were used to pre-determine sample 
sizes but our sample sizes are similar to those reported in previous publications (15, Fancy et 
al., Genes Dev 23, 1571 (2009)(16, Fancy et al., Nat Neurosci 14, 1009 (2011). Data 
collection and analysis were performed blind to the conditions of the experiment. Data were 
collected and processed randomly, and animals were randomly assigned to treatment groups.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Fig. 1. 
Common markers of high activity Wnt signaling across diverse tissue types. (a) Schematic 
to show strategy for comparison of mRNA transcripts upregulated in Wnt-activated OPCs 
(Olig2cre/DA-Cat)(15) with those upregulated in human colon carcinomas (3). (b) The 
markers LEF1, SP5, RNF43, ETS2 and DUSP4 are expressed in human colon 
adenocarcinoma. Scale bar represents 15 μm.
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Fig. 2. 
High activity Wnt signaling causes permanent OPC maturation arrest. (a) OPCs lacking 
APC fail to undergo a differentiation program during development and fail to express 
mRNAs for multiple mature oligodendrocyte markers, including MRF, CNPase, and MAG, 
as seen at postnatal day 15 (P15) in the spinal cord (SC) of Olig2-cre, APCfl/fl mice. Scale 
bar represents 100 μm. (b) APC-deficient OPCs expressed greatly elevated levels of the Wnt 
transcriptional target Axin2 in P9 SC (which remains elevated at P120), and remain 
persistently undifferentiated as late as P650. Scale bar represents 300 μm (left panel), 10 μm 
(right panels).
Fancy et al. Page 12
Nat Neurosci. Author manuscript; available in PMC 2014 October 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Fig. 3. 
The switch to high-activity Wnt signaling in colon cancer (4) involves a switch from a 
TCF4-β–catenin to a LEF1-β–catenin complex (a). Once activated, LEF1 (absent in normal 
colon) participates in a feed-forward loop driving its own expression. (b) Lef1 is not 
expressed during normal oligodendrocyte development in Olig2-cre, APCfl/+ heterozygous 
mice (which have lost one allele of APC in oligodendrocyte lineage), but there is robust 
expression of Lef1 mRNA in the corpus callosum (CC)(Scale bar represents 70 μm) and 
Lef1 protein in spinal cord (SC)(Scale bar represents 30 μm) of Olig2-cre, APCfl/fl animals 
at postnatal day 15 (P15) and P9 respectively, and these cells expressed high levels of Axin2 
(black arrows inset). Conversely, Axin2 was not detected in the APC-intact, Tcf4-positive 
OPCs (arrowheads)(Scale bar represents 10 μm).
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Fig. 4. 
Novel markers of high activity Wnt signaling in OPCs. (a) OPCs in Olig2-cre, APCfl/fl 
spinal cord at P9 and P15 express the high threshold Wnt signaling markers SP5, Dusp4 and 
Ets2, whereas these are undetectable in mice with heterozygous loss of one APC allele in 
oligodendrocyte lineage. Scale bar represents 60 μm. (b) High threshold Wnt signaling 
markers are expressed in Nkx2.2+ and Olig2+ OPCs in SC and corpus callosum (CC) of 
Olig2-cre, APCfl/fl mice. Scale bar represents 15 μm.
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Fig. 5. 
Transcription factor SP5 is a Wnt target that inhibits mature oligodendrocyte gene 
expression. SP5 was the most highly upregulated transcription factor in Wnt-activated 
OPCs. (a) Sp5 is a target of the Wnt pathway in OPCs in vitro. There are predicted Tcf4 
binding sites at the SP5 promoter locus, and ChIP demonstrates Tcf4 binding at these 
predicted sites in OPCs. (b) Sp5 transcription is increased with Wnt pathway activation, as 
SP5 luciferase reporter gene activation was observed in the presence of β-catenin (dominant 
active SY33) and endogenous Tcf4 in OPCs, and was inhibited by transfection of dominant-
negative Tcf4 (dnTCF4) (t test * p< 0.05). (c) MBP luciferase reporter gene activation in 
vitro in OPCs is inhibited by transfection with SP5, and this also inhibited SP1-induced 
activation of MBP enhancer activity (t test * p< 0.05, ** p<0.01). (d) ChIP showed that SP5 
directly bound multiple myelin gene promoter loci (MBP, MAG, MAL, FA2H, CNPase) in 
OPCs but not mature oligodendrocytes while the converse was observed for SP1. (e) 
Oligodendrocyte development proceeds normally in SP5−/− animals with normal expression 
of CNPase and MBP mRNA at P1 and P9 respectively in the SC, and MBP protein in SC 
and CC. Scale bar represents 100 μm. (f) SP5 expression is seen in a subset of Olig2+ cells 
during wildtype mouse remyelination at 7dpl (Scale bar represents 10 μm). SP5−/− animals 
showed acceleration of OPC differentiation in the mouse model of remyelination using focal 
injection of lysolecithin into adult spinal cord white matter, with significant increases in 
number of cells expressing PLP mRNA at 7 days post lesioning (7dpl) and 14dpl (t test * p 
= 0.0002, ** p = 0.04, n=4). (g) SP5−/− animals showed acceleration of OPC differentiation 
during remyelination and precocious expression of myelin genes Plp, Cnp, Mag, Mbp and 
Fa2h at 7dpl compared to wildtype (WT) animals. Scale bar represents 100 μm. Error bars 
represent s.d.
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Fig. 6. 
OPCs in human neonatal WMI express multiple genes in common with colon cancer. (a) 
Subcortical WMI occurs in human term infants that suffer severe hypoxic-ischemic 
encephalopathy (HIE). (b) High threshold Wnt signaling marker LEF1 is expressed in a 
subset of Olig2+ oligodendrocyte lineage cells in human HIE. (c) A proportion of immature 
OPCs (Nkx2.2+) co-expressed LEF1 (c) and SP5 (d) in these lesions and were always APC-
negative (e). (g) Immature OPCs in such lesions expressed additional markers of high 
threshold Wnt signaling (ETS2, DUSP4). RNF43 was expressed in cells with the simple 
bipolar morphology of OPCs in neonatal WMI (f), and in a chronic WMI lesion from a 12-
year old child with cerebral palsy (h). LEF1 and SP5 were not expressed by either GFAP+ 
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astrocytes (i) or inflammatory cells expressing CD45 or CD24 markers (j) in lesions of 
human HIE. Scale bars represent 10 μm.
Fancy et al. Page 17
Nat Neurosci. Author manuscript; available in PMC 2014 October 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Fig. 7. 
Loss of Wnt repressor tone determines transition to pathological Wnt signaling. (a) High 
threshold wnt marker Lef1 is expressed at very low levels in wildtype (WT) mouse 
remyelination (lysolethicin focal injection spinal cord)(Scale bar represents 100 μm) at 
14dpl and is not increased by intraperitoneal injection of LPS during remyelination, but Lef1 
expression increased very significantly in lesions inversely to wnt tone in Axin2−/− or 
Olig2-cre, APCfl/fl mice (a and b). (c) APC-null oligodendrocytes show a permanent block 
in differentiation to a remyelinating stage with persistence of Lef1 and Axin2 expression at 
90 days after injury (90dpl). Scale bar represents 10 μm. (d) Wnt repressor function 
regulates neonatal WMI, as demonstrated using mild/chronic neonatal hypoxemia in 
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developing mice (10% FiO2, postnatal day 3–7). Hypoxia in wildtype mice (WT HX) causes 
only transient delay of myelination at P11 (data not shown) with full recovery of corpus 
callosum thickness (d) and striatal thickness (e) to wildtype normoxic levels (WT NX) by 
P40 (Scale bars represent 50 μm). Axin2−/− mice kept in normoxic conditions (Axin2 NX) 
have similar white matter volumes to WT animals at P40. Axin2−/− mice kept in hypoxic 
conditions (Axin2 HX) demonstrate significantly reduced corpus callosum thickness (2 way 
ANOVA *p = 0.023, n=4) and striatum white matter volumes (2 way ANOVA **p = 
0.0009, n=4) at P40 compared with WT HX. Error bars represent s.e.m.
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